Search details
1.
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.
Br J Cancer
; 130(6): 1023-1035, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38238427
2.
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Breast Cancer Res Treat
; 2024 May 20.
Article
in English
| MEDLINE | ID: mdl-38767786
3.
Early Detection and Prediction of Anthracycline-Induced Cardiotoxicityã- A Prospective Cohort Study.
Circ J
; 88(5): 751-759, 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38462534
4.
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
BMC Med
; 20(1): 136, 2022 04 25.
Article
in English
| MEDLINE | ID: mdl-35462552
5.
Characteristics of Cancers in Adolescents and Young Adults Compared with Those in Adults in Their 60s: A Single-Center Experience.
Oncology
; 100(3): 140-147, 2022.
Article
in English
| MEDLINE | ID: mdl-35100598
6.
Absolute Lymphocyte Count as an Independent Prognostic Factor in Metastatic Breast Cancer: A Retrospective Study.
Oncology
; 100(11): 591-601, 2022.
Article
in English
| MEDLINE | ID: mdl-36099888
7.
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.
Int J Clin Oncol
; 27(2): 281-300, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35022887
8.
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1.
Int J Clin Oncol
; 27(2): 265-280, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34973107
9.
[Factors Affecting Adherence to Adjuvant Endocrine Therapy in Japanese Patients with Breast Cancer-An Observational Study].
Gan To Kagaku Ryoho
; 49(10): 1077-1086, 2022 Oct.
Article
in Japanese
| MEDLINE | ID: mdl-36281599
10.
Neoantigen prediction in human breast cancer using RNA sequencing data.
Cancer Sci
; 112(1): 465-475, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33155341
11.
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial.
Breast Cancer Res Treat
; 188(1): 117-131, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33763789
12.
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
Invest New Drugs
; 39(1): 217-225, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32833136
13.
[Describing the Burdens on Patients and Healthcare Providers for Outpatient Chemotherapy-A Proceedings Paper].
Gan To Kagaku Ryoho
; 48(10): 1233-1239, 2021 Oct.
Article
in Japanese
| MEDLINE | ID: mdl-34657054
14.
A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer.
Breast Cancer Res Treat
; 180(1): 135-146, 2020 Feb.
Article
in English
| MEDLINE | ID: mdl-31953696
15.
Elevated Production of Mitochondrial Reactive Oxygen Species via Hyperthermia Enhanced Cytotoxic Effect of Doxorubicin in Human Breast Cancer Cell Lines MDA-MB-453 and MCF-7.
Int J Mol Sci
; 21(24)2020 Dec 15.
Article
in English
| MEDLINE | ID: mdl-33333736
16.
Adjuvant Olaparib in BRCA-Mutated Breast Cancer.
N Engl J Med
; 385(15): 1439-1440, 2021 Oct 07.
Article
in English
| MEDLINE | ID: mdl-34614337
17.
The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial.
Breast Cancer Res Treat
; 176(3): 625-630, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-30806921
18.
Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Cancer Sci
; 108(3): 362-372, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-28012234
19.
Correction to: Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.
Int J Clin Oncol
; 27(3): 635-637, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35152344
20.
FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.
Cancer Sci
; 107(3): 281-9, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26708273